The effects of some beta adrenergic blocking agents on the central and peripheral actions of tremorine and oxotremorine.
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000494:pharmacology; D000526:Alprenolol / Q000494:pharmacology; D000605:Amino Alcohols / Q000494:pharmacology*; D000818:Animals; D001285:Atropine / Q000494:pharmacology*; D002490:Central Nervous System / Q000187:drug effects; D004336:Drug Antagonism; D004983:Ethanolamines / Q000494:pharmacology*; D007035:Hypothermia / Q000517:prevention & control; D008297:Male; D051379:Mice; D010095:Oxotremorine / Q000037:antagonists & inhibitors; D010277:Parasympathomimetics / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology*; D013565:Sympatholytics / Q000494:pharmacology*; D014202:Tremor / Q000517:prevention & control; D014203:Tremorine / Q000037:antagonists & inhibitors* / Q000378:metabolism
D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D004983:Ethanolamines; D010277:Parasympathomimetics; D013565:Sympatholytics; D010095:Oxotremorine; D001285:Atropine; D000526:Alprenolol; D011433:Propranolol; D014203:Tremorine